Quick treatment following minor stroke reduces risk of major stroke by 80%

1 Rothwell PM and others 2 Lavallée PC and others

The Lancet and the Lancet Neurology.

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. www.thelancet.com Published online October 9, 2007 DOI:10.1016/S0140-6736(07)61448-2

A transient ischaemic attack clinic with round-the clock access (SOS-TIA): feasibility & effects. http://neurology.thelancet.com Published online October 9, 2007 DOI:10.1016/S1474-4422(07)70248-X Lancet Neurol 2007; 6: 953–60.  Read File..

Metabolic Syndrome predicts Diabetes in the elderly, but not Cardiovascular disease

Naveed Sattar and others

Lancet - Published online May 22, 2008

Article, Comment, Press Release attached

Tony Kirby
Press Officer
The Lancet
32 Jamestown Road
Camden
London
NW1 7BY

Tel: +44 (0) 20 7424 4949

E-mail: pressoffice@lancet.com

  Read File..

Intrabone Administration of unrelated Cord-Blood Cells is Successfull in Enabling More Patients with Acute Leukaemia to Undergo Transplantation

Francesco Frassoni and others

Lancet Oncoloy - Published online August 9, 2008

Article and Press Release attached

Tony Kirby
Press Officer
The Lancet
32 Jamestown Road
Camden
London
NW1 7BY

Tel: +44 (0) 20 7424 4949
Mob: +44 (0) 7920 592635

E-mail: pressoffice@lancet.com
  Read File..

Stress: decreasing CV risk

Brotman, D and others:

the Lancet. 2007; 370: 1089–1000.

The cardiovascular toll of stress.   Read File..

Daytime and night-time BP are both vital prognostic indicators.

J Boggia and others

Lancet. 2007:370;1219-1229.

Prognostic accuracy of day versus night ambulatory blood pressure.  Read File..

Combination drug therapy to lower BP could reduce cardiovascular outcomes for people with type 2 diabetes

ADVANCE Collaborative Group

www.thelancet.com Published Online

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. www.thelancet.com Published Online September 2, 2007 DOI:10.1016/S0140-6736(07)61303-8
  Read File..

Rosiglitazone and pioglitazone increase risk of CHF but not the risk of CV death

RM Lago, PP Singh, R W Nesto

Lancet 2007; 370: 1129–36

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones randomised clinical trials.

  Read File..